Next Article in Journal
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds
Previous Article in Journal
Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
Previous Article in Special Issue
mRNA-Loaded Lipid Nanoparticles Targeting Immune Cells in the Spleen for Use as Cancer Vaccines
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Pharmaceuticals 2023, 16(7), 967; https://doi.org/10.3390/ph16070967
Action Date Notes Link
article xml file uploaded 6 July 2023 08:59 CEST Original file -
article xml uploaded. 6 July 2023 08:59 CEST Update https://www.mdpi.com/1424-8247/16/7/967/xml
article pdf uploaded. 6 July 2023 08:59 CEST Version of Record https://www.mdpi.com/1424-8247/16/7/967/pdf
article html file updated 6 July 2023 09:00 CEST Original file -
article html file updated 6 July 2023 09:00 CEST Update -
article html file updated 20 July 2023 20:48 CEST Update https://www.mdpi.com/1424-8247/16/7/967/html
Back to TopTop